| 1 |
World Health Organization. Novel Coronavirus (2019-nCoV) situation report-22 [EB/OL].(2020-02-11)[2020-04-01].
URL
|
| 2 |
国家卫生健康委办公厅，国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案（试行第七版）的通知[EB/OL]. (2020-03-03)[2020-04-01].
URL
|
| 3 |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med, 2020, 382(18):1708-1720.
|
| 4 |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395 (10223):507-513.
|
| 5 |
Watanabe Y, Tsuchiya A, Seino S, et al. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice[J]. Stem Cells Transl Med, 2019, 8(3):271-284.
|
| 6 |
Kojima Y, Tsuchiya A, Ogawa M, et al. Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions[J]. Regen Ther, 2019, 11:269-281.
|
| 7 |
Chen J, Hu C, Chen L, et al. Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment[J]. Engineering (Beijing), 2020. doi: 10.1016/j.eng.2020.02.006. |
| 8 |
黄梁浒，陈津，付云烽, 等. 间充质干细胞制备及质量控制技术规范[J/CD]. 中华细胞与干细胞杂志:电子版, 2019, 9(6):321-329.
|
| 9 |
Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[J]. Aging Dis, 2020, 11(2):216-228.
|
| 10 |
古利明，李涛，曾勇, 等.人脐带间充质干细胞联合抗病毒等方法治疗新型冠状病毒肺炎[J]. 昆明医科大学学报, 2020, 41(3):96-100.
|
| 11 |
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020. doi: 10.1001/jama.2020.2648. Online ahead of print. |
| 12 |
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020, 382(13):1199-1207.
|
| 13 |
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature,2020, 579(7798):270-273.
|
| 14 |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
|
| 15 |
Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial[J]. JAMA, 2012, 307(11): 1169-1177.
|
| 16 |
Fu X, Liu G, Halim A, et al. Mesenchymal stem cell migration and tissue repair[J]. Cells, 2019, 8(8):784.
|
| 17 |
Qin ZH, Xu JF, Qu JM, et al. Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism[J]. J Cell Mol Med, 2012, 16(11): 2745-2753.
|
| 18 |
Curley GF, Hayes M, Ansari B, et al. Mesenchymal stem cells enhance recovery and repair following ventilatorinduced lung injury in the rat[J]. Thorax, 2012, 67(6): 496-501.
|
| 19 |
鞠秀丽. 间充质干细胞治疗新型冠状病毒肺炎的潜在机制和研究进展[J]. 山东大学学报(医学版), 2020, 58(3):32-37.
|